Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by Aubreyon Jan 22, 2015 9:55pm
265 Views
Post# 23354299

trading is clever, but is it wise ?

trading is clever, but is it wise ?Traders are keeping real investors with deep pockets away from this, "could have been a darling stock"   The "vulture exchange" is nothing more than the sum of it's parts. So don't blame it..YOU are it.  " It's unfortunate the rat data was a miserable failure. "  For the traders...delaying the short term gain would have yielded more profit. 
  
   Had you boneheads not dumped on the news, as per the traders dictum, TLT would have be over $1...and been well on her way. This short term greed scared away $40M .possibly $100M of investments. Traders short term greed is certainly interfearing with the greater good.
  
  The "transferrin modality" was not something new, this news mearly explaines how the PDCs were able to localize into the cancer cells 180x the healthy cells...as shown in the rat data.  Roger had to file the letter of intent for a patent before the Bermuda conference, as he would have been asked how the PDCs were able to localize, by the med, pros, at the conference. 
 I don't speed read stockhouse for information, I read to access the quality of the individuals involved. 
I see the youth lacks widom and wealth, as per usual...unable to delay gratification.
   Personally, I was hoping our next cancer indication would challenge colon cancer and then breast cancer...befor brain cancer    because ...(wait for it.)    .I value tit-s and a-ss before brains.
cheers
Bullboard Posts